Jade Biosciences (JBIO) Other Non-Current Assets (2021 - 2026)

Jade Biosciences (JBIO) has 6 years of Other Non-Current Assets data on file, last reported at $69000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets changed N/A year-over-year to $69000.0; the trailing twelve-month figure through Mar 2026 stood at $69000.0 (changed N/A YoY), and the FY2025 full-year result was $69000.0, down 97.81% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $69000.0, roughly flat from $69000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $3.1 million in Q4 2024 and bottomed at $60000.0 in Q2 2025.
• The 5-year median for Other Non-Current Assets is $903500.0 (2022), against an average of $1.3 million.
• The widest annual swing landed in 2022, when Other Non-Current Assets surged 747.68%; it then plunged 97.81% in 2025.
• A 5-year view of Other Non-Current Assets shows it stood at $2.6 million in 2022, then slipped by 10.78% to $2.3 million in 2023, then surged by 37.7% to $3.1 million in 2024, then slumped by 97.81% to $69000.0 in 2025, then changed by 0.0% to $69000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $69000.0 (Q1 2026), $69000.0 (Q4 2025), and $174000.0 (Q3 2025), per Business Quant data.

Peer Comparison